• $636,573.00
    Market Cap
  • -63.27%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 33
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0008
$0.001
$0.0009
1-Year Range
$0.0007
$0.003
$0.0009
Latest Close$0.0009
Change
$0.00 (0.00%)
Volume25,310
Market Cap$636,573.00
Shares Outstanding707.3M
P/E (TTM)-1.50
Diluted EPS (TTM)-$0.0006
Enterprise Value$985,345.00

Information as of 07/30/2026

Company Profile

$636,573.00
Market Cap
-$297,172.00
Net Income
Sector: Healthcare
Industry: Biotechnology
PO Box 25, Jackson Center, PA, United States, 16133
814 786 8849

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Key Executives

  • John S. Borza
  • Heidi H. Carl
  • Patricio F. Reyes FAAN
  • Mitchell S. Felder
  • William A. Hartman

Current Ownership Distribution

  • Other515.9M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)